background
acut
viral
respiratori
ill
children
subsaharan
africa
receiv
rel
littl
attent
although
much
frequent
caus
morbid
mortal
develop
countri
although
acut
respiratori
ill
major
caus
morbid
mortal
among
children
subsaharan
africa
receiv
rel
littl
attent
unfortun
underli
diseas
aid
malaria
tuberculosi
highli
preval
region
worsen
ill
respiratori
virus
known
caus
acut
ill
includ
human
respiratori
syncyti
viru
hrsv
human
parainfluenza
viru
piv
human
metapneumoviru
influenza
virus
recent
burden
influenza
influenzalik
ill
africa
consid
neglig
mainli
lack
confirm
assay
report
cameroon
seneg
howev
show
influenza
virus
activ
circul
may
caus
regular
epidem
clear
pictur
contribut
pathogen
acut
respiratori
ill
need
order
improv
prevent
clinic
manag
consequ
reduc
burden
diseas
emerg
novel
influenza
swine
origin
mexico
april
rapid
spread
worldwid
caus
global
pandem
led
health
author
central
african
republ
car
collabor
world
health
organ
strengthen
biolog
surveil
acut
respiratori
ill
aim
studi
report
determin
circul
pandem
influenza
viru
molecular
method
identifi
caus
virus
incid
clinic
featur
acut
respiratori
ill
among
infant
young
children
sentinel
site
bangui
three
rural
area
infant
children
age
year
attend
sentinel
site
bangui
three
rural
area
figur
influenzalik
ill
ili
sever
acut
respiratori
ill
januari
decemb
includ
studi
figur
world
health
organ
definit
use
ili
sudden
onset
fever
cough
sore
throat
absenc
diagnos
sever
acut
respiratori
ill
ili
symptom
short
breath
difficulti
breath
requir
hospit
admiss
studi
protocol
approv
nation
ethic
committe
car
individu
written
inform
consent
sought
parent
guardian
particip
nasopharyng
sampl
collect
infant
children
within
hr
nation
influenza
centr
use
rayonbud
swab
viru
transport
medium
preimpregn
spong
virocult
medic
wire
equip
uk
rna
extract
qiamp
rna
mini
kit
qiagen
accord
manufactur
instruct
influenza
virus
detect
previous
describ
assay
target
conserv
matrix
gene
univers
detect
virus
viru
identifi
specif
onestep
realtim
revers
transcriptionpolymeras
chain
reaction
rtpcr
assay
design
nation
influenza
centr
northern
franc
institut
pasteur
pari
primer
probe
avail
upon
request
gripp
pasteurfr
specimen
also
test
respiratori
virus
two
previous
describ
multiplex
seminest
rtpcr
assay
detect
influenza
b
virus
hrsv
human
metapneumoviru
piv
type
assay
perform
abi
platform
appli
biosystem
foster
citi
california
usa
superscript
iii
platinum
onestep
quantit
rtpcr
system
invitrogen
carlsbad
california
usa
specimen
consid
posit
signal
curv
cross
threshold
line
within
cycl
assay
limit
detect
pandem
influenza
viru
order
magnitud
initi
sampl
assay
limit
detect
influenza
b
virus
hrsv
human
metapneumoviru
order
magnitud
assay
limit
detect
order
magnitud
copi
amplif
pcr
product
purifi
sent
gatc
biotech
konstanz
germani
sequenc
student
test
pearson
chisquar
test
use
assess
intergroup
differ
statist
analys
perform
epiinfo
softwar
v
cdc
test
consid
signific
p
valu
newli
obtain
sequenc
analys
compar
sequenc
avail
genbank
patient
includ
studi
test
posit
respiratori
virus
tabl
five
posit
influenza
b
hrsv
tabl
figur
averag
age
posit
patient
month
rang
month
year
differ
age
gender
distribut
sampl
neg
human
metapneumoviru
first
case
detect
car
juli
child
age
month
follow
second
case
septemb
infant
age
month
three
case
found
young
children
octob
figur
five
children
one
admit
intens
care
respiratori
distress
death
record
fragment
haemagglutinin
gene
five
strain
access
number
show
high
sequenc
similar
influenza
data
shown
specimen
posit
influenza
b
repres
influenza
virus
detect
ten
patient
hospit
one
infant
age
month
die
day
admiss
intens
care
clinic
pictur
sever
acut
respiratori
ill
influenza
b
viru
implic
respiratori
infect
hrsv
detect
patient
tabl
median
age
month
mainli
novemb
figur
one
infant
age
month
die
day
admiss
intens
care
clinic
pictur
fever
cough
rhiniti
bronchiol
dyspnoea
myalgia
fever
rhiniti
record
patient
cough
viral
coinfect
report
analysi
nucleotid
sequenc
six
isol
access
number
show
sequenc
similar
genotyp
b
detect
seven
patient
median
age
month
rang
month
four
infant
median
age
month
rang
month
april
novemb
figur
respiratori
virus
found
collect
sampl
show
presenc
infect
car
first
time
found
influenza
b
hrsv
also
involv
ili
countri
case
detect
raini
season
infect
car
first
describ
juli
african
countri
viru
shown
introduc
travel
sourc
car
elucid
four
case
detect
indigen
histori
travel
contact
person
return
countri
declar
case
extens
investig
contact
confirm
case
reveal
case
suggest
low
dissemin
countri
clinic
pictur
infect
similar
season
influenza
circul
pandem
accord
studi
show
rel
low
transmiss
sever
consequ
appear
signific
public
health
impact
area
world
present
studi
influenza
b
viru
commonli
detect
respiratori
viru
wherea
similar
studi
africa
hrsv
frequent
caus
viru
ili
influenza
b
viru
caus
respiratori
infect
throughout
year
two
peak
begin
raini
season
junejuli
end
raini
season
novemb
antigen
genet
distinct
lineag
influenza
b
viru
influenza
bvictoria
byamagata
virus
circul
car
hrsv
major
caus
ili
among
infant
children
worldwid
frequent
detect
respiratori
viru
develop
develop
countri
studi
hrsv
found
sampl
repres
virus
detect
differ
studi
might
due
differ
epidemiolog
hrsv
car
landlock
countri
central
africa
differ
inclus
criteria
detect
techniqu
hrsv
case
detect
studi
occur
novemb
februari
correspond
dri
season
car
anoth
interest
find
rel
low
preval
respiratori
virus
children
ili
present
sampl
similar
studi
mani
sampl
contain
respiratori
virus
car
vaccin
streptococcu
pneumonia
haemophilu
influenza
introduc
enlarg
programm
vaccin
recent
h
influenza
septemb
pneumonia
juli
studi
bangui
bacteria
found
hundr
ill
children
age
less
year
therefor
like
bacteria
still
common
even
main
caus
respiratori
infect
car
countri
introduct
vaccin
sever
respiratori
infect
due
bacteri
infect
pneumonia
h
influenza
commonest
bacteri
caus
may
explain
least
partli
differ
result
studi
also
possibl
virus
look
involv
human
rhinoviru
human
bocaviru
human
coronaviru
adenoviru
main
limit
studi
limit
sampl
size
prevent
us
investig
associ
clinic
outcom
viral
etiolog
anoth
weak
bia
toward
younger
patient
could
assess
whether
particular
age
group
greater
risk
specif
infect
owe
design
studi
also
difficult
determin
preval
result
therefor
studi
need
evalu
burden
respiratori
virus
infect
gener
popul
car
studi
highlight
import
clinic
epidemiolog
virolog
network
influenza
surveil
car
report
first
data
etiolog
ili
car
help
central
african
clinician
provid
better
care
treatment
patient
present
ili
includ
better
use
antibiot
studi
patient
need
confirm
burden
viral
respiratori
diseas
car
collect
sampl
healthi
control
children
may
also
enabl
comment
viru
detect
diseas
associ
anoth
suggest
futur
studi
collect
data
underli
health
statu
children
risk
factor
hiv
infect
malaria
malnutrit
etc
might
impact
acut
respiratori
infect
tempor
pattern
detect
assess
mani
year
order
identifi
longterm
season
pattern
abbrevi
car
central
african
republ
ili
influenzalik
ill
hrsv
human
respiratori
syncyti
viru
piv
parainfluenza
virus
